Overview

Evaluation of the Efficacy, Safety, and Tolerability of Sarizotan in Rett Syndrome With Respiratory Symptoms

Status:
Terminated
Trial end date:
2020-07-24
Target enrollment:
Participant gender:
Summary
This study evaluates the safety, tolerability and efficacy of Sarizotan in reducing respiratory abnormalities in Rett Syndrome.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Newron
Newron Pharmaceuticals SPA